Literature DB >> 29696398

Neurobehçet, multiple sclerosis or overlap syndrome? A case report.

Vittorio Mantero1, Andrea Rigamonti2, Anna Fiumani2, Luisa De Toni Franceschini2, Ugo Pozzetti3, Roberto Balgera2, Andrea Salmaggi2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29696398     DOI： 10.1007/s10072-018-3420-4

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  15 in total

1.  Behçet's disease patients with multiple sclerosis-like features: discriminative value of Barkhof criteria.

Authors:  Gulsen Akman-Demir; Melike Mutlu; Asli Kiyat-Atamer; Erkingul Shugaiv; Murat Kurtuncu; Ilknur Tugal-Tutkun; Erdem Tuzun; Mefkure Eraksoy; Sara Bahar
Journal:  Clin Exp Rheumatol       Date:  2015-10-19       Impact factor: 4.473

Review 2.  Optic chiasmal neuritis.

Authors:  N J Newman; S Lessell; J M Winterkorn
Journal:  Neurology       Date:  1991-08       Impact factor: 9.910

3.  A case of Behçet's disease with development of MS-like lesions in the CNS and spinal cord.

Authors:  Ranko Aoyagi; Tsutomu Sakai; Yu Kono; Yasuyuki Iguchi; Hiroshi Tsuneoka
Journal:  Clin Exp Rheumatol       Date:  2013-09-09       Impact factor: 4.473

4.  Indirect meta-analytical comparison of azathioprine and of beta interferon effectiveness in all forms of multiple sclerosis pooled together.

Authors:  Andrea Messori; Valeria Fadda; Dario Maratea; Sabrina Trippoli
Journal:  J Neurol Sci       Date:  2014-10-22       Impact factor: 3.181

Review 5.  Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.

Authors:  Alan J Thompson; Brenda L Banwell; Frederik Barkhof; William M Carroll; Timothy Coetzee; Giancarlo Comi; Jorge Correale; Franz Fazekas; Massimo Filippi; Mark S Freedman; Kazuo Fujihara; Steven L Galetta; Hans Peter Hartung; Ludwig Kappos; Fred D Lublin; Ruth Ann Marrie; Aaron E Miller; David H Miller; Xavier Montalban; Ellen M Mowry; Per Soelberg Sorensen; Mar Tintoré; Anthony L Traboulsee; Maria Trojano; Bernard M J Uitdehaag; Sandra Vukusic; Emmanuelle Waubant; Brian G Weinshenker; Stephen C Reingold; Jeffrey A Cohen
Journal:  Lancet Neurol       Date:  2017-12-21       Impact factor: 44.182

Review 6.  Neurological Complications of Therapeutic Monoclonal Antibodies: Trends from Oncology to Rheumatology.

Authors:  Chandler Gill; Stasia Rouse; Ryan D Jacobson
Journal:  Curr Neurol Neurosci Rep       Date:  2017-08-17       Impact factor: 5.081

7.  A clinical comparative study of multiple sclerosis and neuro-Behçet's syndrome.

Authors:  S Motomura; T Tabira; Y Kuroiwa
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-03       Impact factor: 10.154

8.  Interferon-β or azathioprine as add-on therapies in patients with active multiple sclerosis.

Authors:  Veronika Ticha; Tomas Kalincik; Eva Havrdova
Journal:  Neurol Res       Date:  2012-08-21       Impact factor: 2.448

Review 9.  Azathioprine for multiple sclerosis.

Authors:  I Casetta; G Iuliano; G Filippini
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17

10.  Azathioprine versus beta interferons for relapsing-remitting multiple sclerosis: a multicentre randomized non-inferiority trial.

Authors:  Luca Massacesi; Irene Tramacere; Salvatore Amoroso; Mario A Battaglia; Maria Donata Benedetti; Graziella Filippini; Loredana La Mantia; Anna Repice; Alessandra Solari; Gioacchino Tedeschi; Clara Milanese
Journal:  PLoS One       Date:  2014-11-17       Impact factor: 3.240
View more
  1 in total

1.  Developmental venous anomalies in patients with multiple sclerosis: is that a coincidence or an ancillary finding?

Authors:  Irene Grazzini; Benedetta Calchetti; Gian Luca Cuneo
Journal:  Neurol Sci       Date:  2020-10-21       Impact factor: 3.307
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.